Metropolis Completes Acquisition of Dr. Ahuja’s Pathology & Imaging Centre

Mumbai, May 24, 2025 — Metropolis Healthcare Ltd (NSE: METROPOLIS, BSE: 542650) has formally announced the successful completion of its acquisition of Dr. Ahuja’s Pathology & Imaging Centre (DAPIC) through its wholly owned subsidiary, Dapic Metropolis Healthcare Private Limited.

Acquisition Effective from May 23

This strategic acquisition, concluded as a going-concern, brings the entire business operations of DAPIC previously operated by Dr. Alok Ahuja and Dr. Alka Ahuja under the umbrella of Metropolis. The deal was executed in line with the terms defined under the Business Transfer Agreement and became effective on May 23, 2025.

Following the completion, operations of the acquired business will now be carried out under Dapic Metropolis Healthcare Private Limited, formerly known as Metropolis Histoxpert Digital Services Private Limited.

Strengthening Market Presence

This acquisition is a part of Metropolis’s broader strategy to consolidate and expand its footprint in India’s diagnostic healthcare space. DAPIC, a reputed name in the pathology and imaging segment, is expected to enhance Metropolis’s service portfolio, geographical reach, and customer base.

Regulatory Compliance

The transaction has been disclosed in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring compliance with listing norms.

This acquisition reflects Metropolis’s ongoing commitment to growth through strategic alliances and investments in high-quality diagnostic infrastructure.

Source: https://nsearchives.nseindia.com/corporate/METROPOLIS_24052025104609_Stock_Exchange_Dapic_Completion.pdf